Literature DB >> 21057842

How parkinsonism influences life: the patients' point of view.

E Martignoni1, Antonietta Citterio, R Zangaglia, L Godi, C Pacchetti, C Fundarò, E Corengia, G Bono, G Nappi.   

Abstract

To explore the experience of living with parkinsonism, a survey form was sent to the members of a patients' association; 1,256 forms were analysed. The mean age was 65.75 ± 9.29 years; 64.4% males. A family history was reported by 19.2%. Basic abilities were preserved in 75% of the responders; the ability to do indoor and outdoor activities was preserved in 42 and 28%, respectively. 70% of the responders liked to meet other people and about 50% liked discussing their condition. 80.3% of the responders lived with partner, while 7.8% did not live with family. Of the patients' partners, 38.9% took drugs, and 9.4% themselves needed assistance. Care programmes for parkinsonians should take into account the disease duration, the degree of disability, the presence of caregiver/s, and the level of caregiver burden; but it should also be appreciated that social habits, need of help, and severity of symptoms influence disability.

Entities:  

Mesh:

Year:  2010        PMID: 21057842     DOI: 10.1007/s10072-010-0435-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  The Disability Discrimination Act, a necessary, but not sufficient safeguard for people with progressive conditions in the workplace? The experiences of younger people with Parkinson's disease.

Authors:  Pauline Banks; Maggie Lawrence
Journal:  Disabil Rehabil       Date:  2006-01-15       Impact factor: 3.033

2.  Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross-sectional study in Croatia.

Authors:  N Klepac; S Pikija; T Kraljić; M Relja; V Trkulja; S Juren; I Pavlicek; T Babić
Journal:  Eur J Neurol       Date:  2007-02       Impact factor: 6.089

Review 3.  Stress as a modulator of motor system function and pathology.

Authors:  Gerlinde A Metz
Journal:  Rev Neurosci       Date:  2007       Impact factor: 4.353

4.  Occupational titles as risk factors for Parkinson's disease.

Authors:  Smita Dick; Sean Semple; Finlay Dick; Anthony Seaton
Journal:  Occup Med (Lond)       Date:  2006-10-17       Impact factor: 1.611

5.  Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

Authors:  Anette Schrag; Anna Hovris; David Morley; Niall Quinn; Marjan Jahanshahi
Journal:  Parkinsonism Relat Disord       Date:  2005-11-03       Impact factor: 4.891

6.  Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients.

Authors:  Olivia Leoni; Emilia Martignoni; Marco Cosentino; Donatella Michielotto; Daniela Calandrella; Roberta Zangaglia; Giulio Riboldazzi; Cristina Oria; Sergio Lecchini; Giuseppe Nappi; Gianmario Frigo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-03       Impact factor: 2.890

7.  Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.

Authors:  Mariese A Hely; John G L Morris; Wayne G J Reid; Robert Trafficante
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

8.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 9.  Levodopa responsiveness in disorders with parkinsonism: a review of the literature.

Authors:  Radu Constantinescu; Irene Richard; Roger Kurlan
Journal:  Mov Disord       Date:  2007-11-15       Impact factor: 10.338

Review 10.  Gender differences in Parkinson's disease.

Authors:  Lisa M Shulman
Journal:  Gend Med       Date:  2007-03
View more
  1 in total

1.  Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial.

Authors:  Ingrid H W M Sturkenboom; Maud J Graff; George F Borm; Eddy M M Adang; Maria W G Nijhuis-van der Sanden; Bastiaan R Bloem; Marten Munneke
Journal:  Trials       Date:  2013-02-02       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.